Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.24 | N/A |
| PEG Ratio (TTM) | -2.96 | N/A |
| P/S Ratio (TTM) | 2.64 | N/A |
| P/B Ratio (TTM) | 1.14 | N/A |
| P/FCF Ratio (TTM) | 22.83 | N/A |
| Price to 5YR AVG Earnings Ratio | 410.62 | N/A |
| Price to 5YR AVG FCF Ratio | 54.30 | N/A |
Profitability (38%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.44% | N/A |
| ROE (TTM) | 7.86% | N/A |
| Net Profit Margin (TTM) | 18.61% | N/A |
| ROIC 5YR AVG | 1.49% | N/A |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 196.28% | -131.59% | -21.75% |
| Revenue | -1.75% | 3.43% | 19.51% |
| Net Income | 214.75% | -113.30% | -9.72% |
| Cash Flow | 1.49% | -6.84% | 122.43% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.22 | N/A |
| Quick Ratio (TTM) | 0.22 | N/A |
| D/E Ratio (TTM) | 0.38 | N/A |
| Interest Coverage (TTM) | 2.25 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.82 | N/A |
| LTL to 5YR AVG FCF | 9.06 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.85% | N/A |